Product Offerings
Products:
Antibiotics: NA
Anti-inflammatories: NA
Antiparasitics: NA
Nutritional Supplements: NA
Vaccines: NA
Industrial Veterinaria, S.A. (INVESA), a LIVISTO company, is a globally recognized manufacturer and distributor of veterinary pharmaceutical products dedicated to improving animal health and productivity. Headquartered in Barcelona, Spain, INVESA is part of the LIVISTO Group, which unifies the operations of several established veterinary brands across Europe, Latin America, and Asia.
With a portfolio covering essential therapeutic segments including antibiotics, antiparasitics, anti-inflammatories, nutritional supplements, and vaccines, INVESA serves veterinarians, livestock producers, and pet owners in over 90 countries. The company leverages over 45 years of experience in veterinary health and is known for its commitment to innovation, regulatory excellence, and customer-centric service.
Core Business
INVESA’s core business centers around the research, manufacturing, registration, and global distribution of veterinary medicines for both food-producing and companion animals. The company's therapeutic coverage includes:
- Anti-infectives (antibiotics and antiparasitics)
- Anti-inflammatory and analgesic agents
- Supportive therapy and nutritional supplements
- Biologicals and vaccines
- Formulations for oral, injectable, topical, and intramammary administration
Their business model includes branded generic formulations, licensing partnerships, and custom contract manufacturing for third-party clients.
Product and Service Offerings
Food-Producing Animals
- Antibiotics for swine, cattle, sheep, and poultry (injectables and water-soluble formulations)
- Antiparasitics including endectocides and coccidiostats
- Anti-inflammatories for mastitis, lameness, and fever management
- Vitamin and mineral supplements for metabolic support and recovery
- Vaccines targeting major production diseases (limited markets)
Companion Animals
- Oral and injectable antibiotics
- NSAIDs and corticosteroids
- Dewormers (broad-spectrum)
- Dermatological and ophthalmic solutions
- Nutraceuticals for mobility, digestion, and immunity
All products are developed with species-specific safety, efficacy, and pharmacokinetics in mind and supported by ongoing pharmacovigilance.
Specialisation and Core USP
INVESA, as a part of LIVISTO, differentiates itself through:
- Complete regulatory lifecycle management, ensuring fast market access globally
- Integrated manufacturing with EU-GMP and PIC/S compliant facilities
- Multispecies coverage, allowing clients to source multiple solutions from a single partner
- Affordable, quality-driven therapeutic alternatives to branded originator products
- Global logistics and pharmacovigilance network
Their cross-continental presence enables localized formulations, regulatory compliance, and post-marketing support in diverse regulatory environments.
Financials
While specific revenue figures are not public, indicators of INVESA's financial strength and market footprint include:
- Presence in over 90 countries
- LIVISTO Group turnover estimated at over €100 million
- Manufacturing and distribution hubs in Spain, Germany, and Latin America
- Investment in new product development and dossier registrations, especially in MENA and Asia-Pacific
- Continuous growth in companion animal segment, driven by rising pet care expenditures
The company’s integration into LIVISTO has expanded its scale and market agility, enabling competitive pricing and wider distribution.
Shipments and Usage Metrics
According to trade and industry sources:
- Annual exports of millions of units of injectables, tablets, and feed additives
- Strong sales in Latin America, Southeast Asia, Eastern Europe, and North Africa
- Repeat procurement by public veterinary services and private distributors
- Flagship products include injectable oxytetracyclines, ivermectin formulations, and multivitamin solutions
Distribution is supported by a network of over 150 local partners, veterinarians, and licensing agents.
Target Market
INVESA targets a broad veterinary client base:
- Veterinarians and clinics
- Livestock producers and integrators
- Feed and veterinary product distributors
- Ministries of agriculture and public animal health programs
- Private label and contract manufacturing clients
Their offerings span both the intensive farming systems and the rapidly expanding companion animal segment.
Capabilities
- EU-GMP certified manufacturing plant in Barcelona with capabilities in sterile and non-sterile dosage forms
- Formulation and analytical development laboratories
- Regulatory affairs and dossier registration for EU and ROW markets
- Global pharmacovigilance system
- B2B services including contract development and supply (CDMO)
INVESA also invests in customer education, training, and technical support, delivered through field veterinarians and digital platforms.
Certifications and Compliance
- EU-GMP certification
- ISO 9001 certified
- Compliant with European Medicines Agency (EMA) and World Organisation for Animal Health (WOAH) standards
- Multiple product registrations under national authorities in LATAM, ASEAN, MENA, and Sub-Saharan Africa
- Active pharmacovigilance and batch traceability systems
All manufacturing batches undergo rigorous QC testing, and products are supported with full regulatory dossiers for global submission.
Customer Testimonials
- "We’ve worked with INVESA for 15 years. Their products are effective, affordable, and consistently meet our regulatory needs." – Distributor, Central America
- "As a veterinarian, I trust their injectable antibiotics for fast response and minimal withdrawal times." – Veterinary Practitioner, North Africa
Major Achievements
- Key contributor to livestock health programs across Asia and Africa
- Expansion of the LIVISTO brand portfolio into more than 90 countries
- Establishment of multi-regional GMP manufacturing capacity
- Successfully navigated complex regulatory approvals for over 200 products
- Recognized for contract manufacturing and B2B partnerships with top-tier animal health companies
Industrial Veterinaria, S.A. – a LIVISTO company – continues to deliver high-quality veterinary pharmaceuticals that meet the evolving needs of animal health professionals across the globe. Its strength lies in a blend of European manufacturing excellence, global regulatory acumen, and deep customer partnerships.